Fatty acid-binding protein 5 (FABP5) was found in our previous study to be a potential biomarker for lymph node metastasis of cervical cancer. However, the roles of FABP5 in cervical cancer remain unclear. In the present study, FABP5 expression was found to be significantly upregulated in cervical cancer tissues, and high FABP5 expression was significantly correlated with lymph node metastasis, lymphovascular space invasion, the International Federation of Gynecology and Obstetrics (FIGO) stage, and tumor size. Moreover, FABP5 was an independent factor for poor prognosis in cervical cancer patients. Silencing of FABP5 inhibited cell proliferation, colony formation, cell migration, and invasion in vitro. Furthermore, FABP5 silencing significantly reduced tumor growth and lung metastases in a murine allograft model in vivo. In addition, FABP5 silencing decreased the expression of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) in vitro and in vivo. Collectively, these findings indicated that FABP5 plays an important role in the carcinogenesis and metastasis of cervical cancer, and FABP5 may be a novel predictor for prognostic assessment of cervical cancer patients.
Cervical cancer Metastasis Prognosis FABP5
This is a preview of subscription content, log in to check access.
This work is supported by the Sun Yat-sen University Clinical Research 5010 Program (grant number 2007010), the Guangdong Natural Science Fund (grant number 2016A030310147, S2013010015448), and the Science and Technology Program of Guangzhou (grant number 201510010289).
Compliance with ethical standards
Conflicts of interest
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA. A Cancer Journal for Clinicians. 2015;65:87–108.CrossRefGoogle Scholar
Lin LF, Chuang CH, Li CF, Liao CC, Cheng CP, Cheng TL, et al. Zbrk1 acts as a metastatic suppressor by directly regulating mmp9 in cervical cancer. Cancer Res. 2010;70:192–201.CrossRefPubMedGoogle Scholar
Chen YF, Chiu WT, Chen YT, Lin PY, Huang HJ, Chou CY, et al. Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis. Proc Natl Acad Sci U S A. 2011;108:15225–30.CrossRefPubMedPubMedCentralGoogle Scholar
He SY, Shen HW, Xu L, Zhao XH, Yuan L, Niu G, et al. Foxm1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer. Gynecol Oncol. 2012;127:601–10.CrossRefPubMedGoogle Scholar
Wang W, Jia HL, Huang JM, Liang YC, Tan H, Geng HZ, et al. Identification of biomarkers for lymph node metastasis in early-stage cervical cancer by tissue-based proteomics. Br J Cancer. 2014;110:1748–58.CrossRefPubMedPubMedCentralGoogle Scholar
Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr. 2008;28:73–95.CrossRefPubMedGoogle Scholar
Jeong CY, Hah YS, Cho BI, Lee SM, Joo YT, Jung EJ, et al. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma. Oncol Rep. 2012;28:1283–92.PubMedGoogle Scholar
Adamson J, Morgan EA, Beesley C, Mei Y, Foster CS, Fujii H, et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene. 2003;22:2739–49.CrossRefPubMedGoogle Scholar
Campos B, Centner FS, Bermejo JL, Ali R, Dorsch K, Wan F, et al. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. Am J Pathol. 2011;178:1953–64.CrossRefPubMedPubMedCentralGoogle Scholar
Liu RZ, Graham K, Glubrecht DD, Germain DR, Mackey JR, Godbout R. Association of fabp5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy. Am J Pathol. 2011;178:997–1008.CrossRefPubMedPubMedCentralGoogle Scholar
Chen Y, Lin C, Liu Y, Jiang Y. Hmgb1 promotes hcc progression partly by downregulating p21 via erk/c-myc pathway and upregulating mmp-2. Tumour Biol. 2015.Google Scholar
Fang LY, Wong TY, Chiang WF, Chen YL. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med. 2010;39:342–8.CrossRefPubMedGoogle Scholar
Levi L, Lobo G, Doud MK, von Lintig J, Seachrist D, Tochtrop GP, et al. Genetic ablation of the fatty acid-binding protein fabp5 suppresses her2-induced mammary tumorigenesis. Cancer Res. 2013;73:4770–80.CrossRefPubMedPubMedCentralGoogle Scholar
Jing C, Beesley C, Foster CS, Rudland PS, Fujii H, Ono T, et al. Identification of the messenger rna for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res. 2000;60:2390–8.PubMedGoogle Scholar
Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat rama 37 model cells. Cancer Res. 2001;61:4357–64.PubMedGoogle Scholar
Powell CA, Nasser MW, Zhao H, Wochna JC, Zhang X, Shapiro C, et al. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. Oncotarget. 2015;6:6373–85.CrossRefPubMedPubMedCentralGoogle Scholar
Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, et al. Uterine cervical carcinoma: role of matrix metalloproteinases. Int J Oncol. 2009;34:897–903 .ReviewPubMedGoogle Scholar